BCL2L11 and non-small cell lung carcinoma: Notably, a common BIM deletion has been shown to confer intrinsic resistance to tyrosine kinase inhibitors in NSCLC cell lines and to be associated with shorter progression-free survival in EGFR-driven NSCLC42.